New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway.

Translated title of the contribution: New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway.

N.W.C.J. van de Donk, A.C. Bloem, E. van der Spek, H.M. Lokhorst

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway.
Original language	Undefined/Unknown
Pages (from-to)	327-340
Number of pages	14
Journal	Current Pharmaceutical Design
Volume	12
Issue number	3
Publication status	Published - 2006

Cite this

@article{af57b42424bf49f29cb2613214f9370f,

title = "New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway.",

author = "{van de Donk}, N.W.C.J. and A.C. Bloem and {van der Spek}, E. and H.M. Lokhorst",

year = "2006",

language = "Undefined/Unknown",

volume = "12",

pages = "327--340",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}